|
|
||||||||
Original Research |
Research Division, Hospital for Special Surgery, New York, New York
Laboratory for Fluorescence Dynamics, Physics Department, University of Illinois, Urbana-Champaign, Urbana, Illinois
Department of Microbiology and Immunology, Weill Medical College, Cornell University, New York, New York
State University of New York at Stony Brook, School of Medicine, Stony Brook, New York
Division of Endocrinology, Clinical Nutrition and Vascular Medicine, University of California, Davis Medical Center, Sacramento, California
Division of Rheumatology, University of Washington, Seattle, Washington
Division of Rheumatology, University of Washington, Seattle, Washington
Section of Endocrinology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin and Geriatrics Research, Education and Clinical Center, William S. Middleton Veterans Hospital, Madison, Wisconsin
REPRINT REQUESTS: Robert D. Blank, MD, PhD, Section of Endocrinology, Department of Medicine, University of Wisconsin-Madison, H4/556 CSC (5148), 600 Highland Avenue, Madison, Wisconsin 53792, Telephone: 608-263-7780, Fax: 608-263-9983, Email: rdb{at}medicine.wisc.edu
OBJECTIVE
Development of a systematic mutation detection assay strategy for denaturing high performance liquid chromatography (DHPLC).
DESIGN
Adaptation of Guanine and Cytosine (GC)-clamping from denaturing gradient gel electrophoresis (DGGE) to DHPLC.
METHODS
Three target sequences harboring known allelic variants were studied to develop a general DHPLC assay design strategy. These were exon 10 of the human RET (REarranged during Transfection) gene, exon 52 of the mouse Colla2 gene, and exon 9 of the human FAS (APO-1, CD-95) gene. Available software was used to analyze melting curves and determine assay conditions. GC clamps of 20 bp or 36 bp were added to polymerase chain reaction (PCR) primers to introduce a high melting temperature (Tm) domain to each of the target molecules. DHPLC was performed under partially denaturing conditions.
RESULTS
DHPLC assays of PCR-amplified sequences can be developed using a personal computer. The following three steps allowed for mutation detection in all three targets.
8° above that of the target sequence should be appended to one of the primers.
90% double stranded CONCLUSION
Addition of GC-clamps to primers facilitates mutation detection by DHPLC.
The theoretical basis for this observation is identical to that underlying the utility of GC-clamps in DGGE.
Key Words: Heterozygote detection Nucleic acid denaturation Genetic screening Polymerase chain reaction
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |